Why Semaglutide Can Cause Headaches There are several reasons headaches may occur when taking semaglutide or other GLP-1 medications: 1
48% discontinuation among weight loss GLP-1 users 33% discontinuation among diabetes GLP-1 users Discontinuation of GLP-1 therapy is associated with metabolic rebound, including weight regain, rising blood pressure, and worsening glycemic control, undermining both clinical outcomes and the value of initial investment
1, 2027, representing reductions of approximately 50% and 35% for Wegovy and Ozempic, respectively, according to Novo Nordisk
But research over the past several years has made one thing clear: The brain plays a central role in how these drugs suppress appetite
Each of the selected impurities elicited an IFN- response in a greater number of donors when compared to Forteo ( Figure 7 , hashed grey bars)
These mechanisms help explain why Akkermansia muciniphila benefits are often discussed in relation to gut barrier support, GLP-1 sensitivity, and metabolic resilience
